| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $5.2B | $5.8B | $4.5B | $3.5B | $3.4B | $3.1B | $2.9B | $2.8B |
| Cost of Revenue | $1.4B | $1.6B | $1.3B | $1.1B | $1.0B | $1.0B | $0.9B | $1.0B |
| Gross Profit | $3.7B | $4.2B | $3.2B | $2.4B | $2.4B | $2.1B | $1.9B | $1.9B |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | — | — | — | — | — | — | — | — |
| Operating Income | $0.9B | $0.9B | $0.5B | $0.6B | $0.7B | $0.5B | $0.6B | $0.5B |
| Net Income | $0.4B | $0.5B | $0.2B | $0.4B | $0.3B | $0.2B | $0.3B | $0.2B |
| EPS (Basic) | $1.66 | $1.71 | $0.56 | $1.46 | $1.14 | $0.86 | $1.06 | $0.91 |
| EPS (Diluted) | $1.65 | $1.71 | $0.56 | $1.46 | $1.14 | $0.86 | $1.06 | $0.91 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $13.8B | $14.2B | $17.1B | $10.2B | $9.6B | $10.2B | $7.9B | $7.8B |
| Current Assets | $2.2B | $2.3B | $2.3B | $2.3B | $2.2B | $2.4B | $1.6B | $1.3B |
| Cash & Equivalents | $1.2B | $1.3B | $1.2B | $1.7B | $1.6B | $1.7B | $0.9B | $0.7B |
| Total Liabilities | — | — | — | — | — | — | — | — |
| Current Liabilities | $2.7B | $2.8B | $3.2B | $1.5B | $1.4B | $1.9B | $1.0B | $1.0B |
| Stockholders' Equity | $3.9B | $4.2B | $4.0B | $4.0B | $4.1B | $4.0B | $3.9B | $3.7B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $0.8B | $1.0B | $0.8B | $1.0B | $0.9B | $1.0B | $0.9B | $0.7B |
| Investing Cash Flow | $-0.2B | $2.1B | $-5.7B | $-1.0B | $-0.1B | $-1.5B | $-0.5B | $-0.4B |
| Capital Expenditures | — | — | — | — | — | — | — | — |
| Financing Cash Flow | $-0.8B | $-3.0B | $4.4B | $0.1B | $-0.9B | $1.3B | $-0.1B | $-0.0B |